DocGo Inc. (NASDAQ:DCGO) Expected to Announce Quarterly Sales of $110.41 Million

Wall Street brokerages forecast that DocGo Inc. (NASDAQ:DCGOGet Rating) will report sales of $110.41 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for DocGo’s earnings, with estimates ranging from $105.32 million to $115.50 million. The business is scheduled to announce its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that DocGo will report full year sales of $411.97 million for the current fiscal year, with estimates ranging from $403.74 million to $420.20 million. For the next year, analysts anticipate that the business will report sales of $469.62 million, with estimates ranging from $450.00 million to $489.24 million. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover DocGo.

DCGO has been the topic of a number of analyst reports. Needham & Company LLC restated a “buy” rating and set a $14.00 target price on shares of DocGo in a research report on Wednesday, March 16th. Stifel Nicolaus initiated coverage on DocGo in a research report on Wednesday, January 19th. They set a “buy” rating and a $14.00 price target on the stock. began coverage on DocGo in a report on Tuesday, December 21st. They issued a “buy” rating and a $13.00 price objective for the company. Finally, Zacks Investment Research raised DocGo from a “hold” rating to a “buy” rating and set a $9.25 target price on the stock in a report on Thursday, March 17th. Six research analysts have rated the stock with a buy rating, According to MarketBeat, DocGo presently has an average rating of “Buy” and a consensus target price of $14.38.

NASDAQ:DCGO traded up $0.13 during mid-day trading on Friday, reaching $8.88. 406,175 shares of the company’s stock were exchanged, compared to its average volume of 721,520. DocGo has a one year low of $5.63 and a one year high of $11.86. The business’s fifty day moving average is $7.69.

Large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new position in DocGo in the 4th quarter valued at approximately $9,186,000. Penserra Capital Management LLC bought a new position in shares of DocGo in the 4th quarter valued at $50,000. Wall Street Access Asset Management LLC acquired a new stake in shares of DocGo during the 4th quarter valued at $108,000. Light Street Capital Management LLC acquired a new stake in shares of DocGo during the 4th quarter valued at $24,282,000. Finally, Mirabella Financial Services LLP bought a new stake in DocGo during the 4th quarter worth $185,000. 32.58% of the stock is currently owned by institutional investors and hedge funds.

DocGo Company Profile (Get Rating)

DocGo, Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Further Reading

Get a free copy of the Zacks research report on DocGo (DCGO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.